E-nitiateBio

Hangzhou, China · Founded 2020 · Privately Held (backing)

Developer of new drugs designed for autoimmune diseases. E-nitiateBio is based in Hangzhou, China and was founded in 2020. It has raised $42.6 million.

Last price · $/share
—
Implied valuation
—
Total raised
$42.6M
Last round
—

Who backs E-nitiateBio?

11 investors
InvestorType
Highlight CapitalOther
Fuzhe CapitalAsset manager
HFI Investment GroupOther
Taikun FundOther
Hangzhou Linzhuo Industry InvestmentOther
Hangzhou Industry Investment GroupOther
Betta Pharmaceuticals—
Hangzhou Betta Investment—
Momentum Venture—
TIME Investments—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

E-nitiateBio investors

11 investors are on record for E-nitiateBio, including Highlight Capital, Fuzhe Capital, HFI Investment Group and Taikun Fund.

Free account
More of E-nitiateBio with a free account
  • ·The complete investor list: 11 names
  • ·Watch E-nitiateBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like E-nitiateBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View